THROMBOCYTOPENIA
Clinical trials for THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection aims to protect cancer patients from Chemotherapy's Blood-Thinning danger
Disease control CompletedThis early-stage study tested a new injection called PN20, given right before chemotherapy, to see if it could safely prevent a dangerous drop in platelets (the cells that help blood clot). It involved 24 adults with lymphoma or solid tumors who had experienced low platelets duri…
Matched conditions: THROMBOCYTOPENIA
Phase: PHASE1 • Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New test may better predict who will benefit from platelet transfusions
Knowledge-focused CompletedThis study aimed to see if a newer lab test (C1q-binding) could better predict how well a patient will respond to a platelet transfusion compared to the standard test (IgG). Researchers analyzed stored blood samples from 68 patients with low platelet counts who had become resista…
Matched conditions: THROMBOCYTOPENIA
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC
-
Scientists seek blood clues to stop cancer treatment bleeding
Knowledge-focused CompletedThis study collected a single blood sample from 40 adult cancer patients with very low platelet counts. The goal was to provide fresh blood for lab testing of a potential future artificial platelet product. This research aims to help develop treatments that could reduce bleeding …
Matched conditions: THROMBOCYTOPENIA
Sponsor: Case Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC
-
Drug copycat test: does the new pill work the same?
Knowledge-focused CompletedThis study tested if a new version of a drug called eltrombopag, used to treat low platelet counts, works the same way in the body as the original version. It involved 36 healthy Chinese volunteers who took both versions of the pill after a meal. The main goal was to compare how …
Matched conditions: THROMBOCYTOPENIA
Phase: NA • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:25 UTC